Telephone
61.3.9095.3036
Address
Level 2 971 Burke Road Camberwell, Victoria (VIC) 3124
Description
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. It operates through the following segments: MedAdvisor and Corporate. The MedAdvisor segment includes medication management and adherence platform. The Corporate segment comprises of the company's function associated with being an ASX listed company. MedAdvisor was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.16 - 0.31
Trade Value (12mth)
AU$17,854.00
1 week
-2.33%
1 month
23.53%
YTD
-19.23%
1 year
5%
All time high
1.725
EPS 3 yr Growth
-48.900%
EBITDA Margin
-2.40%
Operating Cashflow
-$1m
Free Cash Flow Return
-2.80%
ROIC
-21.90%
Interest Coverage
-1.10
Quick Ratio
0.80
Shares on Issue (Fully Dilluted)
536m
HALO Sector
Technology
Next Company Report Date
29-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.01
Date | Announcements |
---|---|
31 July 23 |
4C Q4 FY23 Medadvisor Quarterly Update - 31 July 2023
×
4C Q4 FY23 Medadvisor Quarterly Update - 31 July 2023 |
31 August 22 |
Application for quotation of securities - MDR
×
Application for quotation of securities - MDR |
31 August 18 |
MedAdvisor FY18 Annual Report & Appendix 4E
×
MedAdvisor FY18 Annual Report & Appendix 4E |
30 September 14 |
Exalt Resources Limited - Annual Report to shareholders (ERD-AU)
×
Exalt Resources Limited - Annual Report to shareholders (ERD-AU) |
30 September 13 |
Exalt Resources Limited - Annual Report to shareholders (ERD-AU)
×
Exalt Resources Limited - Annual Report to shareholders (ERD-AU) |
30 October 23 |
Q1 FY24 MDR Quarterly Update
×
Q1 FY24 MDR Quarterly Update |
30 November 22 |
AGM Presentation
×
AGM Presentation |
30 November 22 |
AGM Chair and CEO Addresses
×
AGM Chair and CEO Addresses |
30 November 22 |
Results of AGM
×
Results of AGM |
30 November 22 |
Constitution
×
Constitution |
30 November 22 |
Notification of cessation of securities - MDR
×
Notification of cessation of securities - MDR |
30 November 22 |
Change of Director's Interest Notice - Read
×
Change of Director's Interest Notice - Read |
30 November 22 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
30 November 22 |
Notification regarding unquoted securities - MDR
×
Notification regarding unquoted securities - MDR |
30 November 22 |
Change of Director's Interest Notice - Ratliff
×
Change of Director's Interest Notice - Ratliff |
30 November 22 |
Change of Director's Interest Notice - Jenkinson
×
Change of Director's Interest Notice - Jenkinson |
30 November 22 |
Change of Director's Interest Notice - Hook
×
Change of Director's Interest Notice - Hook |
30 November 22 |
Change of Director's Interest Notice - Hutchinson
×
Change of Director's Interest Notice - Hutchinson |
30 November 22 |
Change of Director's Interest Notice - Merrow
×
Change of Director's Interest Notice - Merrow |
30 November 22 |
Change of Director's Interest Notice - Xenos
×
Change of Director's Interest Notice - Xenos |
30 November 12 |
Exalt Resources Limited - AGM 2012 Presentation (ERD-AU)
×
Exalt Resources Limited - AGM 2012 Presentation (ERD-AU) |
30 November 12 |
Exalt Resources Limited - AGM / UK Roadshow Investor Presentation (ERD-AU)
×
Exalt Resources Limited - AGM / UK Roadshow Investor Presentation (ERD-AU) |
30 March 23 |
Appointment of Company Secretary
×
Appointment of Company Secretary |
30 August 23 |
MedAdvisor Appendix 4G
×
MedAdvisor Appendix 4G |
30 August 23 |
MedAdvisor Corporate Governance Statement
×
MedAdvisor Corporate Governance Statement |
30 August 23 |
MDR Appendix 4E and FY23 Annual Report
×
MDR Appendix 4E and FY23 Annual Report |
30 August 23 |
MDR delivered strong financial results in FY23
×
MDR delivered strong financial results in FY23 |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.